Dalbeni A, Capoferro E, Bernardoni L, Capelli P, Caliò A, Gabbrielli A, Capra F
Section of Internal Medicine, Department of Biomedical and Surgical Science, University of Verona, 10-37134 Verona, Italy.
Case Rep Gastrointest Med. 2012;2012:698404. doi: 10.1155/2012/698404. Epub 2012 Dec 31.
Ischemic colitis is a serious drug-induced adverse event. There are only few cases of immunosuppression-associated ischemic colitis described in the literature, but none with a pancolitis-like manifestation. We report the case of a 72-year-old female patient who developed a pancolitis with ischemic injury on immunosuppressive treatment with steroids and azathioprine for autoimmune hepatitis. The patient presented with massive rectal bleeding. Colonoscopy confirmed the diagnosis of pancolitis. The results of histological examination indicated drug-induced ischemic colitis involving the entire colon. This is the first case of ischemic pancolitis mimicking an inflammatory bowel disease (IBD) in a patient with immunosuppressive therapy.
缺血性结肠炎是一种严重的药物性不良事件。文献中仅描述了少数几例与免疫抑制相关的缺血性结肠炎病例,但无一例表现为全结肠炎样。我们报告了一例72岁女性患者,该患者因自身免疫性肝炎接受类固醇和硫唑嘌呤免疫抑制治疗后发生了伴有缺血性损伤的全结肠炎。患者出现大量直肠出血。结肠镜检查确诊为全结肠炎。组织学检查结果表明为药物性缺血性结肠炎,累及整个结肠。这是首例在接受免疫抑制治疗的患者中出现类似炎症性肠病(IBD)的缺血性全结肠炎病例。